Inventor · disambiguated record

Tyler Lahusen

Also filed as: LAHUSEN TYLER

31 granted patents·17 pending applications·271 citations·filing 2016–2025

97Inventor score

Technology areasC12N A61K A61P C07K C12Y

Files withAMERICAN GENE TECH INT INC47 AMERICAN GENE TECH INTEMATIONAL INC1

Top patents by PatentIndex Score

48 records

0197US10233464B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Mar 19, 2019·25 cites·14 claims
0297US10137144B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 27, 2018·28 cites·20 claims
0397US10036040B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·30 cites·19 claims
0497US10036038B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·25 cites·18 claims
0597US9914938B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Mar 13, 2018·34 cites·17 claims
0697US9834790B1Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Dec 5, 2017·33 cites·13 claims
0796US10420789B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Sep 24, 2019·13 cites·20 claims
0896US10023880B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 17, 2018·29 cites·11 claims
0995US10472649B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 12, 2019·14 cites·6 claims
1094US11090379B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2019·Granted Aug 17, 2021·5 cites·39 claims
1194US10772905B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Sep 15, 2020·6 cites·14 claims
1293US10888613B2Method of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2017·Granted Jan 12, 2021·5 cites·12 claims
1393US10767183B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2017·Granted Sep 8, 2020·7 cites·24 claims
1493US10494647B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Dec 3, 2019·5 cites·17 claims
1592US10428350B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Oct 1, 2019·7 cites·16 claims
1691US2025121051A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
1789US12370253B2Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Granted Jul 29, 2025·0 cites·10 claims
1888US11612649B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2021·Granted Mar 28, 2023·1 cites·94 claims
1988US11519006B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Dec 6, 2022·1 cites·16 claims
2088US11242527B1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2021·Granted Feb 8, 2022·1 cites·19 claims
2186US11534450B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
2285US12410446B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·13 claims
2385US2024238406A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
2484US12403155B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 2, 2025·0 cites·16 claims
2584US2025121050A1Methods of producing cells resistant to hiv infectionAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
2684US2025042975A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
2784US2023241200A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
2883US2025376685A1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
2982US11911458B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 27, 2024·1 cites·18 claims
3079US12359203B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2022·Granted Jul 15, 2025·0 cites·26 claims
3177US2024141381A1Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3274US12410445B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·17 claims
3374US2024141374A1On demand expression of exogenous factors in lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3474US2025179150A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
3573US10975374B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2020·Granted Apr 13, 2021·0 cites·18 claims
3673US2023285480A1Viral vectors for treating parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
3772US12090200B2Methods of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2020·Granted Sep 17, 2024·0 cites·12 claims
3868US11352646B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
3965US11820999B2Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 21, 2023·0 cites·6 claims
4063US11976292B2Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2016·Granted May 7, 2024·0 cites·12 claims
4163US2024279678A1On demand expression of exogenous factors in lymphocytes to treat hivAMERICAN GENE TECH INT INC·Filed 2021·Application pending·0 cites
4261US11583562B2Viral vectors for treating Parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 21, 2023·0 cites·4 claims
4359US2024075140A1Engineered nk cells and methods of treating cancerAMERICAN GENE TECH INTEMATIONAL INC·Filed 2022·Application pending·0 cites
4457US2019255190A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2017·Application pending·0 cites
4550US2022162643A1Optimized phenylananine hydroxylase expressionAMERICAN GENE TECH INT INC·Filed 2020·Application pending·0 cites
4648US2020318081A1Vectors with promoter and enhancer combinations for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2018·Application pending·0 cites
4746US2020384021A1Hiv immunotherapy with no pre-immunization stepAMERICAN GENE TECH INT INC·Filed 2018·Application pending·0 cites
4838US2018161455A1Non-integrating viral delivery system and methods of use therofAMERICAN GENE TECH INT INC·Filed 2016·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Tyler Lahusen files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →